Trial record 1 of 1 for: "Atrophic Rhinitis" | "Botulinum Toxins, Type A"
Previous Study | Return to List | Next Study
Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00732680|
Recruitment Status : Terminated (Lead investigator moved to a new medical center; study was stopped when he left.)
First Posted : August 12, 2008
Results First Posted : February 13, 2014
Last Update Posted : April 18, 2016
Information provided by (Responsible Party):
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Empty Nose Syndrome
Drug: Botulinum Toxin Type A
No study data was collected in the study. The Lead investigator moved to a new medical center; the study was stopped when he left.